Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Comprehensive molecular profiling in patients with advanced biliary tract cancers (BTC) in a Latinx-rich cohort.
Authors
Vidit Kapoor
University of Texas at San Antonio Department of Hematology and Oncology, San Antonio, TX;
Vidit Kapoor , Sylvia Keiser , Qianqian Liu , Joel Michalek , Sukeshi Patel Arora
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 605)
DOI
10.1200/JCO.2023.41.4_suppl.605
Abstract #
605
Poster Bd #
F17
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Genomic targetability and survival outcomes of biliary tract cancers (BTC): A retrospective cohort study of the Australian Molecular Screening and Therapeutics (MoST) program.
First Author: Subotheni Thavaneswaran
Poster
2021 ASCO Annual Meeting
Clinical outcomes analysis of TP53-mutated advanced and metastatic biliary tract cancers.
First Author: Sunyoung S. Lee
Poster
2018 Gastrointestinal Cancers Symposium
Integrative whole exome, transcriptome, and clinical profiling of biliary tract cancers (BTCs).
First Author: Nguyen H. Tran
Poster
2016 ASCO Annual Meeting
Clinical Impact of extensive molecular profiling (EMP) in advanced cancer patients (pts) referred to early phase trial unit: The BIP (Bergonie Institute Profiling) Program.
First Author: Sophie Cousin